Adherence to Combination Antiretroviral Treatment in Children

REFERENCES

• Hogg RS, EaIt KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450–454.
   PubMed Web of Science ®Google Scholar
• PaleIla FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatients Study Investigators. N Engl J Med. 1998;338:853–860.
   PubMed Web of Science ®Google Scholar
• Fatenheuer G, Theisen A, Rockstroh J, et al. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS. 1997;11:F113–F116.
   PubMed Web of Science ®Google Scholar
• Descamps D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously untreated HIV-infected pa-tients from a trial of induction-maintenance therapy. JAMA. 2000;283:205–211.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;33:2–30.
   Google Scholar
• Friedland GH, Williams A. Attaining higher goals in HIV treatment: The central importance of adherence. AIDS. 1999;13\(suppl 1):561–72.
   Google Scholar
• Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999;18:682–689.
   PubMed Web of Science ®Google Scholar
• Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386–395.
   PubMed Web of Science ®Google Scholar
• Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30\(suppl 2):S171–176.
   PubMed Web of Science ®Google Scholar
• Tuldra A, Fumaz CR, Ferrer MJ, et al. A specific interven-tion improves long-term adherence to HAART and ensuing virological outcome. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Che-motherapy; September 26–29, 2000; San Francisco. Ab-stract 595.
   Google Scholar
• Gifford AL, Bormann JE, Shively MJ, et al. Effects of group HIV patient education on adherence to antiretrovirals: A randomized controlled trial. In: Programs and abstracts of the 8th Conference on Retroviruses and Opportunistic In-fections; February 4–8, 2001; Chicago, Illinois. Abstract 479.
   Google Scholar
• Roberts KJ, Volberding P. Adherence communication: A quantitative analysis of physician-patient dialogue. AIDS. 1999;13:1771–1778.
   PubMed Web of Science ®Google Scholar
• Esch LD, Hardy H, Wynn H, Shelton MJ, Hewitt RG, Morse GD. Intensive adherence interventions improve virologic response to antiretroviral therapy (ART) on naive patients. In: Programs and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4–8, 2001; Chicago, Illinois. Abstract 481.
   Google Scholar
• Stenzel M, McKenzie M, Flanigan T, Adelson MJ. A pilot program of modified directly observed therapy (DOT) to enhance adherence to highly active antiretroviral therapy (HAART): 6-month follow-up. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26–29, 2000; San Fran-cisco. Abstract 589.
   Google Scholar
• Fischl M, Castro J, Monroig R, et al. Impact of directly observed therapy on long-term outcomes in HIV clinical trials. In: Programs and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4–8, 2001; Chicago, Illinois. Abstract 528.
   Google Scholar
• Hader SL, Weidle PJ, Cergnul IG, et al. Directly observed antiretroviral therapy (DART) in residential treatment facili-ties in New York City. In: Programs and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4–8, 2001; Chicago, Illinois. Abstract 476.
   Google Scholar
• Haberl A, Gute P, Carlebach A, et al. Once-daily therapy (NVP/dd1/3TC) for the IVDU HIV-1 infected population of the Frankfurt HIV-cohort. Antiviral Ther. 1999;3:55–56.
   Google Scholar
• Molina JM, Ferchal F, Rancinan C, et al. A pilot study of FTC + ddl + efavirenz in treatment-naive HIV-infected adults: A potent and convenient once-a-day HAART (ANRS 091 trial). In: Programs and abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections; January 30-Feb-ruary 2, 2000; San Francisco. Abstract 518.
   Google Scholar
• Cohen J, Reddington C, Jacobs D, et al. School-related issues among HIV-infected children. Pediatrics. 1997;100:E8.
   PubMed Web of Science ®Google Scholar
• Gross E, Burr CK, Storm D, Czarniecki L, D'Orlando D. Monitoring treatment adherence in pediatric HIV: Identify-ing the issues from providers and families. In: Conference record of the 12th World AIDS Conference; June 28-July 3, 1998; Geneva. Abstract 32438.
   Google Scholar
• Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41:1–19.
   Google Scholar
• Pratt RJ, Robinson N, Loveday HP, et al. Adherence to antiretroviral therapy: Appropriate use of self-reporting in clinical practice. HIV Clin Trials. 2001;2:146–159.
   PubMedGoogle Scholar
• Hecht FM, Colifax G, Swanson M, Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. In: Programs and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1–5, 1998; Chicago, Illinois. Abstract 15.
   Google Scholar
• Donaghy S, Waugh S, Wallace C, Hooban S, Mitchla Z, Sharland M. Adherence to paediatric antiretroviral therapy. AIDS. 2000;14\(suppl 4):578.
   Google Scholar
• Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immuno-deficiency virus infection. Pediatr Infect Dis J. 2000;19:1148–1153.
   PubMed Web of Science ®Google Scholar
• Tudor-Williams G, St Clair MH, McKinney RE, et al. HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet. 1992;339:15–19.
   PubMed Web of Science ®Google Scholar
• Albano F, Spagnuolo MI, Berni Canani R, Guarino A. Ad-herence to antiretroviral therapy in HIV-infected children in Italy. AIDS Care. 1999;11:711–714.
   PubMed Web of Science ®Google Scholar
• Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M, The Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2000;13:27–40.
   Web of Science ®Google Scholar
• Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:117–125.
   PubMed Web of Science ®Google Scholar
• Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: A necessity for successful HIV combination therapy. AIDS. 1999;13:S271–278.
   PubMed Web of Science ®Google Scholar